Reply to “Real-world registry evidence beware: Old-world risk analysis may not be applicable to new world belatacept utilization”

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	American Journal of Transplantation
DOIs	https://doi.org/10.1016/j.ajt.2025.05.027
State	Accepted/In press - 2025

ASJC Scopus subject areas

@article{f5f17476e29c496283ea2da567b22be5,

title = "Reply to “Real-world registry evidence beware: Old-world risk analysis may not be applicable to new world belatacept utilization”",

author = "Shyfuddin Ahmed and Christopher Blosser and Israni, \{Ajay K.\} and Engels, \{Eric A.\}",

year = "2025",

doi = "10.1016/j.ajt.2025.05.027",

language = "English (US)",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Reply to “Real-world registry evidence beware

T2 - Old-world risk analysis may not be applicable to new world belatacept utilization”

AU - Ahmed, Shyfuddin

AU - Blosser, Christopher

AU - Israni, Ajay K.

AU - Engels, Eric A.

PY - 2025

Y1 - 2025

UR - https://www.scopus.com/pages/publications/105008545384

UR - https://www.scopus.com/pages/publications/105008545384#tab=citedBy

U2 - 10.1016/j.ajt.2025.05.027

DO - 10.1016/j.ajt.2025.05.027

M3 - Letter

C2 - 40419022

AN - SCOPUS:105008545384

SN - 1600-6135

JO - American Journal of Transplantation

JF - American Journal of Transplantation

ER -